Virtue Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Virtue Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$543.48 - $670.97 $195,652 - $241,549	-360 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $37,311 - $44,262	-65 Reduced 15.29%	360 $218,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $189,860 - $232,985	425 New	425 $201,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $1.24 Million - $1.58 Million	-2,597 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $414,554 - $500,897	-761 Reduced 22.66%	2,597 $1.45 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $1.66 Million - $2.16 Million	3,358 New	3,358 $2.09 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtue Capital Management, LLC with notifications on news.